Alegro receives $1.0 million from exercise of warrants



    TORONTO, Dec. 31 /CNW/ - Alegro Health Corp. ("Alegro") (TSX-V: AGO), a
provider of medical, surgical and disability management services, announced
today that Global Healthcare Investments and Solutions ("GHIS") and its
affiliates Shevi Holdings, Inc ("Shevi") and Jaysam Investments, Inc
("Jaysam") have exercised all of their 5,000,000 "A" series warrants for
proceeds to Alegro of $1.0 million, which brings the approximate current cash
position of the group to just over $4.0 million. Alegro announced on July 16,
2007 that it had entered into a strategic alliance with GHIS, wherein it had
began a consulting agreement, established Alegro Health Partners Inc ("AHP")
and GHIS, Shevi and Jaysam provided $1,250,000 via a private placement and
$750,000 via a convertible debenture into AHP. Pursuant to the private
placement, GHIS, Shevi and Jaysam were granted "A" series warrants for
5,000,000 common shares in aggregate at $0.20 each.
    "We are very pleased with the strong vote of confidence we have received
from our strategic partners," said Brenda Rasmussen, President and Chief
Executive Officer of Alegro. "The additional cash will assist with our
acquisition strategy and bolster our management team."

    About Alegro

    Alegro is a leading Canadian healthcare service provider. Through the
Company's subsidiaries - Don Mills Surgical Unit, Work Able Centres, Direct
Health Solutions and CanAm Research - Alegro provides a variety of surgical
procedures, disability management, third-party medical assessments and support
of drug trial administration. With a broad service offering, the growth of the
healthcare service sector and the establishment of AHP for expansion into new
healthcare sectors, Alegro is pursuing an integrated approach and an
aggressive acquisition strategy to become Canada's leading third-party
healthcare service provider. Alegro is listed on the TSX Venture Exchange
under the symbol AGO. For further information, please visit
www.alegrohealth.com.

    NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS
    RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE
    ADEQUACY OR ACCURACY OF THIS RELEASE.

    This press release contains "forward-looking statements" within the
meaning of applicable securities laws, such as statements concerning
anticipated future events, results, circumstances, performance or expectations
that are not historical facts. These statements are not guarantees of future
performance and are subject to numerous risks and uncertainties, including
those described in our regulatory filings. Those risks and uncertainties
include changes in the regulatory and competitive environments. Many of these
risks and uncertainties can affect our actual results and could cause our
actual results to differ materially from those expressed or implied in any
forward-looking statement made by us or on our behalf. All forward-looking
statements in this press release are qualified by these cautionary statements.
These statements are made as of the date of this press release and, except as
required by applicable law, we undertake no obligation to publicly update or
revise any forward-looking statement, whether as a result of new information,
future events or otherwise. Additionally, we undertake no obligation to
comment on analyses, expectations or statements made by third parties in
respect of Alegro, its financial or operating results or its securities.





For further information:

For further information: Brenda Rasmussen, President and CEO, Alegro
Health Corp, (416) 496-6166 x-328, brasmussen@alegrohealth.com; Michael Moore,
Investor Relations, Equicom Group, (416) 815-0700 x 241,
mmoore@equicomgroup.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890